Skip to content
MS
PW-041 Lipid Metabolism Anabolic unreviewed

Sphingolipid Synthesis

Serine + palmitoyl-CoA Ceramide -> sphingomyelin, cerebrosides, gangliosides
Compartment
ER + Golgi
Main tissue
Nervous tissue, all cells
Rate-limiting
Serine palmitoyltransferase (SPT)
Steps
6

Reaction steps

In source order, 6 total

showing 1–6
  1. 1

    Serine + palmitoyl-CoA -> 3-ketosphinganine + CO2 + CoA-SH

    Serine palmitoyltransferase (SPT) 2.3.1.50 ST-0324 Irreversible rate-limiting PLP (B6)
    Notes

    Rate-limiting and committed step; located on the ER.

  2. 2

    3-Ketosphinganine + NADPH -> sphinganine + NADP+

    3-Ketosphinganine reductase 1.1.1.102 ST-0325 Irreversible/directional NADPH
  3. 3

    Sphinganine + fatty acyl-CoA -> dihydroceramide + CoA-SH

    Ceramide synthase (CerS1-6) 2.3.1.24 ST-0326 Irreversible/directional
    Notes

    Six isoforms determine the acyl chain length of the ceramide pool.

  4. 4

    Dihydroceramide -> ceramide

    Notes

    Ceramide is the hub metabolite of all complex sphingolipids and a pro-apoptotic signal.

  5. 5

    Ceramide + phosphatidylcholine -> sphingomyelin + diacylglycerol

    Sphingomyelin synthase (SGMS1/2) 2.7.8.27 ST-0328 Irreversible/directional
    Notes

    Occurs in the Golgi; sphingomyelin is a major myelin and plasma-membrane lipid.

  6. 6

    Ceramide + UDP-glucose -> glucosylceramide + UDP

    Notes

    Entry to the glycosphingolipid/ganglioside series; sequential glycosyltransferases then build lactosylceramide, globosides and gangliosides.

Showing all 6 steps.

Recent literature

Live Europe PMC search

Europe PMC · from cache · sorted by publication date

  1. 1
    Therapeutic potential of the sphingosine kinase 2 inhibitor opaganib.

    Huang F, Zhan P, Shi X, Sun Y, Song X, Sun P, Liu B. · 2026-05-22

    open access unreviewed
  2. 2
    The responsive nucleus: morphological signatures of cellular state.

    Pérez-Venteo A, Bosch-Calvet M, Garcia-Cajide M, Mauvezin C. · 2026-02-19

    cited 3× open access unreviewed
  3. 3
    Sphingolipid homeostasis and dysregulation in liver function and disease.

    Lan J, Pan Z, Dong W, Wang J, Zhang C, Zhang Y, Wu Y, Jin J. · 2026-04-24

    open access unreviewed
  4. 4
    Choline kinase beta promotes psoriasis pathogenesis by regulating sphingolipid metabolism and activating the PI3K/Akt/GSK3β signaling pathway.

    Luo M, Gao J, Jiang M, Zhang Y, Long D, Yan Y, Pan Y, Zhou R, Fang H, Wang H. · 2026-04-23

    unreviewed
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
    L-Serine Attenuates Metabolic and Behavioural Features of Diabetic Neuropathy with Dose-Dependent Central Proteomic Correlates in a Rat Model

    Hamdy M, Khodeer D, Elsakka M, Alaseem A, Mostafa Y, Alharthi A, El-Nablaway M, Tawfik M. · 2026-06-01

    open access unreviewed
  10. 10
    Case Report of Dual Variants in <i>SLC1A4</i> and <i>APOE</i>: A Possible Link Between Amino Acid and Lipid Metabolism.

    Qaisiya M, Altell K, Alhroub W, Ramlawe M, Battocchio E, Guarnieri F, Altamimi M. · 2026-06-21

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.